Literature DB >> 18829676

Recurrence of tuberculosis in a low-incidence setting.

C C Dobler1, A B H Crawford, P J Jelfs, G L Gilbert, G B Marks.   

Abstract

Recurrence of active tuberculosis following treatment of an initial disease episode can occur due to endogenous re-activation or exogenous re-infection. Cases of recurrent tuberculosis in the Australian state of New South Wales between 1994 and 2006 were identified by data linkage analysis with confirmatory review of case notes. Patients with more than one culture-positive disease episode during that time period who had completed treatment for the initial disease episode were included. Genotyping of Mycobacterium tuberculosis was used to determine whether recurrence was likely to be due to re-activation or re-infection. There were 5,723 tuberculosis notifications between 1994 and 2006, 3,731 of which were culture-positive. Fifteen (0.4%) patients had recurrent culture-positive disease over a mean 5.7 yrs of follow-up (crude annual incidence 71 per 100,000 population). Recurrent tuberculosis was attributable to re-activation (indistinguishable strains) in 11 (73%) cases and to re-infection (different strains) in four (27%). In a low-incidence setting of tuberculosis, a control programme incorporating directly observed therapy for active disease resulted in a very low rate of recurrent tuberculosis over a long period of follow-up. Re-infection is less likely than re-activation, but still contributes significantly to the number of cases with recurrent disease.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18829676     DOI: 10.1183/09031936.00104108

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  19 in total

1.  Models to understand the population-level impact of mixed strain M. tuberculosis infections.

Authors:  Rinat Sergeev; Caroline Colijn; Ted Cohen
Journal:  J Theor Biol       Date:  2011-04-16       Impact factor: 2.691

2.  How host heterogeneity governs tuberculosis reinfection?

Authors:  M Gabriela M Gomes; Ricardo Aguas; João S Lopes; Marta C Nunes; Carlota Rebelo; Paula Rodrigues; Claudio J Struchiner
Journal:  Proc Biol Sci       Date:  2012-02-22       Impact factor: 5.349

Review 3.  Orchestration of pulmonary T cell immunity during Mycobacterium tuberculosis infection: immunity interruptus.

Authors:  Samuel M Behar; Stephen M Carpenter; Matthew G Booty; Daniel L Barber; Pushpa Jayaraman
Journal:  Semin Immunol       Date:  2014-10-11       Impact factor: 11.130

Review 4.  Methodological and Clinical Aspects of the Molecular Epidemiology of Mycobacterium tuberculosis and Other Mycobacteria.

Authors:  Tomasz Jagielski; Alina Minias; Jakko van Ingen; Nalin Rastogi; Anna Brzostek; Anna Żaczek; Jarosław Dziadek
Journal:  Clin Microbiol Rev       Date:  2016-04       Impact factor: 26.132

Review 5.  Translating basic science insight into public health action for multidrug- and extensively drug-resistant tuberculosis.

Authors:  Nicholas D Walter; Michael Strong; Robert Belknap; Diane J Ordway; Charles L Daley; Edward D Chan
Journal:  Respirology       Date:  2012-07       Impact factor: 6.424

6.  Exogenous Reinfection as a Cause of Late Recurrent Tuberculosis in the United States.

Authors:  Julia D Interrante; Maryam B Haddad; Lindsay Kim; Neel R Gandhi
Journal:  Ann Am Thorac Soc       Date:  2015-11

Review 7.  In search of a new paradigm for protective immunity to TB.

Authors:  Cláudio Nunes-Alves; Matthew G Booty; Stephen M Carpenter; Pushpa Jayaraman; Alissa C Rothchild; Samuel M Behar
Journal:  Nat Rev Microbiol       Date:  2014-03-03       Impact factor: 60.633

8.  CD271(+) bone marrow mesenchymal stem cells may provide a niche for dormant Mycobacterium tuberculosis.

Authors:  Bikul Das; Suely S Kashino; Ista Pulu; Deepjyoti Kalita; Vijay Swami; Herman Yeger; Dean W Felsher; Antonio Campos-Neto
Journal:  Sci Transl Med       Date:  2013-01-30       Impact factor: 17.956

9.  Tuberculosis in Canada, 2016.

Authors:  J Vachon; V Gallant; W Siu
Journal:  Can Commun Dis Rep       Date:  2018-03-01

10.  Tuberculosis recurrence after completion treatment in a European city: reinfection or relapse?

Authors:  Juan-Pablo Millet; Evelyn Shaw; Angels Orcau; Martí Casals; Jose M Miró; Joan A Caylà
Journal:  PLoS One       Date:  2013-06-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.